The assets of Second Sight Medical (NSDQ:EYES) are going up for auction on June 25.
The developer and manufacturer of implantable visual prosthetics for blind individuals created the only FDA-approved implantable visual prosthetic treatment for severe retinitis pigmentosa. The company said in March that it was winding down its operations amid the financial shock of the COVID-19 pandemic. In April, Second Sight said it took steps to reduce overhead and conserve liquidity ahead of potential partnering, acquiring, or combining with businesses, just days before pricing a $6.8 million offering of its common stock, which closed in May.
The auction will feature Second Sight’s medical device manufacturing equipment, laboratory assets and office furniture located in Sylmar, Calif. Items available include laser systems, oscilloscopes, spectrum analyzers, scientific microscopes, laboratory refrigerators and freezers, ultrasonic cleaners, vacuum pumps, probe systems, computers, office equipment and more, according to a auction company GA Global Partners.
“This is a unique opportunity for technology firms, medical device manufacturing companies, research and development facilities, universities, hospitals and laboratory businesses seeking to acquire name brand, late model, well maintained manufacturing equipment and lab equipment at a fraction of the cost,” said GA Global Partners VP Michael Presto in a news release.
The live virtual auction will take place on June 25, 2020 starting at 10:00 a.m. PDT. Only online bids will be accepted. Physical inspections will be held on June 24, 2020 at 9:00 a.m. to 4:00 p.m. PDT, or by appointment at 12744 San Fernando Rd. Bldg. 4, Sylmar, CA 91342. COVID-19 safety measures will be observed during inspections and pick-ups. Interested parties can pre-register and view auction details at www.gaauction.com.
